Chlorocriptine | CAS 68944-88-7 - Request Quote
Chlorocriptine
| SZ CAT No: | SZ-B089014 |
| CAS No | 68944-88-7 |
| Mol.F. | C32H40ClN5O5 |
| Mol.Wt. | 610.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Chlorocriptine is chemically (6aR,9R)-5-chloro-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide. Chlorocriptine is supplied with detailed characterization data compliant with regulatory guideline. Chlorocriptine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bromocriptine Mesilate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 68944-88-7
Purchase 68944-88-7
Order 68944-88-7
Enquire 68944-88-7
price of 68944-88-7
68944-88-7 Supplier
68944-88-7 Manufacturer
68944-88-7 Exporter
buy high quality Chlorocriptine
Purchase Chlorocriptine
Chlorocriptine suppliers
Chlorocriptine manufacturers
Chlorocriptine price
Order Chlorocriptine
Enquire Chlorocriptine
Chlorocriptine cost
Chlorocriptine Supplier
Chlorocriptine Distributor
Chlorocriptine for Method Validation
Bromocriptine Mesilate Reference Standard
Chlorocriptine for ANDA Filing
Chlorocriptine for Forced Degradation Studies
Chlorocriptine Identification Standards
Chlorocriptine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.